1887
Volume 2023, Issue 3
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

Background: Bronchial asthma affects about 20% of Qatar’s population. The impact of asthma on COVID-19 outcomes is controversial. The aim of this study was to explore the impact of asthma on COVID-19 outcomes and the predictors of COVID-19-related morbidity and mortality in a cohort of asthma patients infected by COVID-19.

Methods: This is a retrospective cohort study of adult patients with asthma infected with COVID-19, who were recruited from Hamad Medical Corporation (HMC), the main healthcare system in Qatar. Patients were matched to a control group of non-asthmatic COVID-19 patients (1:2) based on sex, age, and other comorbidities.

Results: Between March and August 2020, 616 patients with asthma met the inclusion criteria. The need for hospitalization among patients with asthma was independently associated with older age (adjusted odds ratio [aOR] for 10 years, 1.32; 95% confidence interval [CI], 1.13–1.54; = 0.001) and hypertension (aOR, 2.4; 95% CI, 1.43–3.93; = 0.001) but not with the use of inhaled corticosteroids (ICS), long-acting beta2 agonists, montelukast, or tiotropium. Patients with asthma required less hospitalization for COVID-19 than non-asthmatic patients (28.2% vs. 37.3%, respectively; aOR, 0.59; 95% CI, 0.77–0.90; < 0.001). However, admission to the intensive care unit (ICU) was comparable between both groups (3.3% vs. 2.2%; aOR, 1.64; 95% CI, 0.78–3.43; = 0.193).

No difference in mortality rate was observed between the two groups.

Conclusions: In Qatar, adult patients with asthma do not appear to be at higher risk of COVID-19-related hospitalization or ICU admission compared to the general adult COVID-19-infected population. Older age and hypertension were the only significant predictors of COVID-19-related hospitalization among patients with asthma. Further larger studies are required to confirm such an association.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2023.15
2023-07-23
2024-06-14
Loading full text...

Full text loading...

/deliver/fulltext/qmj/2023/3/qmj.2023.15.html?itemId=/content/journals/10.5339/qmj.2023.15&mimeType=html&fmt=ahah

References

  1. Centers for Disease Control and Prevention . Underlying medical conditions associated with high risk for severe COVID-19: Information for healthcare providers. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/underlyingconditions.html. Accessed: March 1, 2022.
    [Google Scholar]
  2. Carli G, Cecchi L, Stebbing J, Parronchi P, Farsi A. Asthma phenotypes, comorbidities, and disease activity in COVID-19: The need of risk stratification. Allergy. 2021 Mar; 76:(3):955–6.
    [Google Scholar]
  3. O’Beirne SL, Salit J, Kaner RJ, Crystal RG, Strulovici-Barel Y. Up-regulation of ACE2, the SARS-CoV-2 receptor, in asthmatics on maintenance inhaled corticosteroids. Respir Res. 2021 Jul 7; 22:(1):200.
    [Google Scholar]
  4. Branco ACCC, Sato MN, Alberca RW. The possible dual role of the ACE2 receptor in Asthma and Coronavirus (SARS-CoV2) infection. Front Cell Infect Microbiol. 2020 Sep 23; 10::550571.
    [Google Scholar]
  5. Matsumoto K, Saito H. Does asthma affect morbidity or severity of COVID-19? J Allergy Clin Immunol. 2020 Jul; 146:(1):55–7.
    [Google Scholar]
  6. Halpin DMG, Faner R, Sibila O, Badia JR, Agisti A. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? Lancet Respir Med. 2020; 8:(5):436–8.
    [Google Scholar]
  7. Mahdavinia M, Foster KJ, Jauregui E, Moore D, Adnan D, Andy-Nweye AB, et al.. Asthma prolongs intubation in COVID-19. J Allergy Clin Immunol Pract. 2020 Jul-Aug; 8:(7):2388–91.
    [Google Scholar]
  8. Hernandez-Galdamez DR, González-Block , Romo-Dueñas DK, Lima-Morales R, Hernández-Vicente IA, Lumbreras-Guzmán M, et al.. Increased risk of hospitalization and death in patients with COVID-19 and pre-existing noncommunicable diseases and modifiable risk factors in Mexico. Arch Med Res. 2020; 51:(7):683–9.
    [Google Scholar]
  9. Santos MM, Lucena EES, Lima KC, Brito AAC, Bay MB, Bonfada D. Survival and predictors of deaths of patients hospitalised due to COVID-19 from a retrospective and multicentre cohort study in Brazil. Epidemiol Infect. 2020; 148::e198.
    [Google Scholar]
  10. Yehia BR, Winegar A, Fogel R, Fakih M, Ottenbacher A, Jesser C, et al.. Association of race with mortality among patients hospitalized with coronavirus disease 2019 (COVID-19) at 92 US hospitals. JAMA Netw Open. 2020; 3:(8):e2018039.
    [Google Scholar]
  11. Sisó-Almirall A, Kostov B, Mas-Heredia M, Vilanova-Rotllan S, Sequeira-Aymar E, Sans-Corrales M, et al.. Prognostic factors in Spanish COVID-19 patients: A case series from Barcelona. PLoS One. 2020; 15:(8):e0237960.
    [Google Scholar]
  12. US CDC . COVID-NET Preliminary Data 30 May 2020. https://gis.cdc.gov/grasp/COVIDNet/COVID19_5.html. Accessed: November 21, 2021.
    [Google Scholar]
  13. Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: A systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis. 2021 Aug 21; 21:(1):855.
    [Google Scholar]
  14. Omrani AS, Almaslamani MA, Daghfal J, Alattar RA, Elgara M, Shaar SH, et al.. The first consecutive 5000 patients with Coronavirus Disease 2019 from Qatar; a nation-wide cohort study. BMC Infect Dis. 2020 Oct 19; 20:(1):777.
    [Google Scholar]
  15. Almazeedi S, Al-Youha S, Jamal MH, Al-Haddad M, Al-Muhaini A, Al-Ghimlas F, et al.. Characteristics, risk factors and outcomes among the first consecutive 1096 patients diagnosed with COVID-19 in Kuwait. EClinicalMedicine. 2020; 24::100448.
    [Google Scholar]
  16. Burjaq R, Omar N, Hammoudeh S, Janahi I. Asthma Management in Qatar: Environmental Challenges and Recommendations. J Environ Sci Public Health. 2020; 4:(4):431–41.
    [Google Scholar]
  17. Bergman J, Ballin M, Nordström A, Nordström P. Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: A nationwide study. Eur J Epidemiol. 2021; 36:(3):287–98.
    [Google Scholar]
  18. Gude-Sampedro F, Fernández-Merino C, Ferreiro L, Lado-Baleato Ó, Espasandín-Domínguez J, Hervada X, et al.. Development and validation of a prognostic model based on comorbidities to predict COVID-19 severity: A population-based study. Int J Epidemiol. 2021; 50:(1):64–74.
    [Google Scholar]
  19. Nystad W, Hjellvik V, Larsen IK, Ariansen I, Helland E, Johansen KI, et al.. Underlying conditions in adults with COVID-19. Underliggende tilstander hos voksne med covid-19. Tidsskr Nor Laegeforen. 2020; 140:(13). doi: 10.4045/tidsskr.20.0512.
    [Google Scholar]
  20. Ramakrishnan S, Nicolau DV Jr, Langford B, Mahdi M, Jeffers H, Mwasuku C, et al.. Inhaled budesonide in the treatment of early COVID-19 (STOIC): A phase 2, open-label, randomised controlled trial. Lancet Respir Med. 2021 Jul; 9:(7):763–72.
    [Google Scholar]
  21. Izquierdo JL, Almonacid C, González Y, Rio-Bermudez CD, Ancochea J, Cárdenas R, et al.. The impact of COVID-19 on patients with asthma. Eur Respir J. 2021 Mar 4; 57:(3):2003142.
    [Google Scholar]
  22. Lee SC, Son KJ, Han CH, Jung JY, Park SC. Impact of comorbid asthma on severity of coronavirus disease (COVID-19). Sci Rep. 2020 Dec 11; 10:(1):21805.
    [Google Scholar]
  23. Dolby T, Nafilyan V, Morgan A, et al.. Relationship between asthma and severe COVID-19: A national cohort study. Thorax. 2023 Feb; 78:(2):120–7. doi: 10.1136/thoraxjnl-2021-218629.
    [Google Scholar]
  24. Shi T, Pan J, Vasileiou E, Robertson C, Sheikh A, Public Health Scotland and the EAVE II Collaborators. Risk of serious COVID-19 outcomes among adults with asthma in Scotland: A national incident cohort study. Lancet Respir Med. 2022 Apr; 10:(4):347–54.
    [Google Scholar]
  25. Zhu Z, Hasegawa K, Ma B, Fujiogi M, Camargo Jr CA, Liang L. Association of asthma and its genetic predisposition with the risk of severe COVID-19. J Allergy Clin Immunol. 2020 Aug; 146:(2):327–9.
    [Google Scholar]
  26. Chhiba KD, Patel GB, Vu THT, Chen MM, Guo A, Kudlaty E, et al.. Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19. J Allergy Clin Immunol. 2020 Aug; 146:(2):307–14. doi: 10.1016/j.jaci.2020.06.010.
    [Google Scholar]
  27. Choi YJ, Park J-Y, Lee HS, Suh J, Song JY, Byun MK, et al.. Effect of asthma and asthma medication on the prognosis of patients with COVID-19. Eur Respir J. 2021 Mar 4; 57:(3):2002226. doi: 10.1183/13993003.02226-2020.
    [Google Scholar]
  28. Schultze A, Walker AJ, MacKenna B, Morton CE, Bhaskaran K, Brown JP, et al.. Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: An observational cohort study using the OpenSAFELY platform. Lancet Respir Med. 2020 Nov; 8:(11):1106–20.
    [Google Scholar]
  29. Peters MC, Sajuthi S, Deford P, Christenson S, Rios CL, Montgomery MT, et al.. COVID-19-related genes in sputum cells in asthma. Relationship to demographic features and corticosteroids. Am J Respir Crit Care Med. 2020 Jul 1; 202:(1):83–90. doi: 10.1164/rccm.202003-0821OC. Erratum in: Am J Respir Crit Care Med. 2020 Dec 15;202(12):1744–46.
    [Google Scholar]
  30. Griesel M, Wagner C, Mikolajewska A, Stegemann M, Fichtner F, Metzendorf M-I, et al.. Inhaled corticosteroids for the treatment of COVID-19. Cochrane Database Syst Rev. 2022 Mar 9; 3:(3):CD015125.
    [Google Scholar]
  31. Infectious Diseases Society of America . Guideline on the treatment and management of COVID-19. idsa-covid-19-gl-tx-and-mgmt-v9.0.1.pdf (idsociety.org). Accessed: July 21, 2022.
    [Google Scholar]
  32. Kaye L, Theye B, Smeenk I, Gondalia R, Barrett MA, Stempel DA. Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic. J Allergy Clin Immunol Pract. 2020 Jul-Aug; 8:(7):2384–5.
    [Google Scholar]
  33. Rogliani P, Lauro D, Di Daniele N, Chetta A, Calzetta L. Reduced risk of COVID-19 hospitalization in asthmatic and COPD patients: A benefit of inhaled corticosteroids? Expert Rev Respir Med. 2021 Apr; 15:(4):561–8. doi: 10.1080/17476348.2021.1850275.
    [Google Scholar]
  34. Sunjaya AP, Allida SM, Di Tanna GL, Jenkins CR. Asthma and COVID-19 risk: A systematic review and meta-analysis. Eur Respir J. 2022 Mar 31; 59:(3):2101209.
    [Google Scholar]
  35. Sunjaya AP, Allida SM, Di Tanna GL, Jenkins C. Asthma and risk of infection, hospitalization, ICU admission and mortality from COVID-19: Systematic review and meta-analysis. J Asthma. 2022 May; 59:(5):866–79.
    [Google Scholar]
  36. Alexander GC, Tajanlangit M, Heyward J, Mansour O, Qato DM, Stafford RS. Use and content of primary care office-based vs telemedicine care visits during the COVID-19 pandemic in the US. JAMA Netw Open. 2020 Oct 1; 3:(10):e2021476. doi: 10.1001/jamanetworkopen.2020.21476.
    [Google Scholar]
  37. Hartnett KP, Kite-Powell A, DeVies J, Coletta MA, Boehmer TK, Adjemian J, et al.. Impact of the COVID-19 pandemic on emergency department visits — United States, January1, 2019–May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69:(23):699–704. doi: 10.15585/mmwr.mm6923e1.
    [Google Scholar]
  38. Bloom CI, Drake TM, Docherty AB, Lipworth BJ Johnston SL, Nguyen-Van-Tam JS, et al.. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: A national, multicentre prospective cohort study using the ISARIC WHO clinical characterisation protocol UK. Lancet Respir Med. 2021 Jul; 9:(7):699–711.
    [Google Scholar]
  39. R2 World Health Organization . (2021). Asthma and covid-19: Scientific brief, 19 April 2021. World Health Organization. https://www.who.int/publications-detail-redirect/who-2019-ncov-sci-brief-asthma-2021.1
    [Google Scholar]
  40. Wang L, Foer D, Bates DW, Boyce JA, Zhou L. Risk factors for hospitalization, intensive care, and mortality among patients with asthma and COVID-19. J Allergy Clin Immunol. 2020; 146:(4):808–12.
    [Google Scholar]
/content/journals/10.5339/qmj.2023.15
Loading
/content/journals/10.5339/qmj.2023.15
Loading

Data & Media loading...

  • Article Type: Research Article
Keyword(s): AsthmaCOVID-19morbidity and mortality
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error